Compare Enzyme (MLN) vs Parcl (PRCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Parcl — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Parcl trades at Rp90.26 (market cap Rp37,18M, Rp6,3M 24h volume). The key difference: Enzyme is far larger — about 3.6× Parcl's market cap, and Parcl's supply is capped (412,3M / 1B PRCL (42%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Parcl for 16 Days on average.
| MLN | PRCL | |
|---|---|---|
Market Cap | Rp134,13M | Rp37,18M |
Volume (24h) | Rp104,56M | Rp6,3M |
Circulating Supply | 3,3M MLN | 412,3M / 1B PRCL (42%) |
Typical Hold Time | 29 Days | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
Parcl is trading at Rp91.564, exhibiting a bearish technical stance with moving averages signaling strong selling pressure, though oscillators are neutral. The current price sits just below the pivot point of Rp94, with immediate support at Rp88. With a market cap of Rp37.59 million and a circulation rate of 42%, the token's on-chain activity remains limited. No major protocol upgrades or ecosystem developments were reported recently.
Overall outlook is cautious due to prevailing bearish momentum and low liquidity. Key opportunities include potential rebounds from oversold RSI levels, while major risks involve high volatility, thin trading volumes, and the token's low market cap making it susceptible to sharp price swings. Investors should monitor for any breakout above Rp94 resistance for a shift in short-term momentum.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Parcl
The Parcl Ecosystem—comprising Parcl, Parcl Labs, and Parcl Limited—develops and governs the Parcl Protocol, a decentralized platform enabling users to take long or short positions on real-world real estate prices. By leveraging world-class real estate data from Parcl Labs, Parcl aims to create a liquid market around the largest asset class globally. The PRCL token powers the ecosystem, offering governance rights, access to Parcl Labs’ data and analytics, and network incentives.
Read more on PRCL →
